SCID newborn screening: What we've learned.

Area of Science:

• Immunology
• Genetics
• Public Health

Background:

• Severe combined immunodeficiency (SCID) is a severe primary immune defect.
• Early detection and treatment are crucial for survival and improved outcomes.
• Traditional screening methods had limitations.

Purpose of the Study:

• To evaluate the impact of newborn screening for SCID.
• To highlight the success of the T-cell receptor excision circle (TREC) test.
• To discuss lessons learned for public health programs.

Main Methods:

• Implementation of TREC testing in newborn screening programs.
• Pilot studies conducted from 2008-2010.
• Nationwide adoption of SCID screening by 2019.

Main Results:

• TREC testing proved successful in pilot studies.
• All US states adopted SCID newborn screening by 2019.
• Screening has drastically changed SCID presentation and management.

Conclusions:

• Newborn screening for SCID is a vital public health measure.
• The TREC test is an effective tool for early SCID detection.
• SCID screening offers valuable insights for other population-based screenings.